Skip to content

Health-related Quality of Life of Patients With Neurogenic Bladder

Effects of Bladder Management on Health-related Quality of Life in Patients With Neurogenic Bladder

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02179073
Enrollment
87
Registered
2014-07-01
Start date
2007-12-31
Completion date
2019-11-14
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurogenic Bladder Dysfunction

Brief summary

Bladder management has a major impact on the quality of life in patients with neurogenic bladder dysfunction. This a prospective investigation of the effects of the method for bladder evacuation on the health-related quality of life in patients with neurogenic bladder dysfunction. The changes in health-related quality of life over time (longitudinal investigation) and the differences between the different methods for bladder evacuation will be investigated. Patients will be given a standardized and validated questionnaire annually for 10 years.

Interventions

None listed

Sponsors

Swiss Paraplegic Research, Nottwil
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals with neurogenic bladder dysfunction

Exclusion criteria

* Insufficient dexterity to fill in the questionnaire * Insufficient proficiency in the German or French language

Design outcomes

Primary

MeasureTime frameDescription
quality of lifeup to year 10Qualiveen questionnaire

Secondary

MeasureTime frameDescription
bladder evacuation methodyear 1, 2, 3, 4, 5, 6, 7, 8, 9, 10method for bladder evacuation (i.e. intermittent catheterization, condom urinal, reflex micturition, transurethral catheter, suprapubic catheter, sacral bladder stimulator, neuromodulation)
urinary tract infectionsyear 1, 2, 3, 4, 5, 6, 7, 8, 9, 10number of annual symptomatic urinary tract infections
patient characteristicstime 0gender, age, type of neurogenic bladder dysfunction, duration of neurogenic bladder dysfunction

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026